Literature DB >> 474618

Inherited interstitial del(Xp) with minimal clinical consequences: with a note on the location of genes controlling phenotypic features.

R Herva, B Kaluzewski, A de la Chapelle.   

Abstract

In a routine cytogenetic investigation of the outpatients of a hospital for the mentally retarded, a 26-year-old women with a presumptive interstitial deletion of the short arm of one of the X chromosomes was found. The same aberration was found in her phenotypically normal mother and in one of her four sisters, all phenotypically normal. By GTG- and QFQ-banding methods, the deletion was interpreted to involve the entire band Xp21 and adjacent parts of p11 and p22. The karyotype is written 46,X,del(X)(pter leads to p22::p11 leads to qter). By autoradiography and Bud R acridine orange technique, the deleted X was the late replicating one in all three affected persons. The deletion apparently causes shortness of stature but no other phenotypic symptoms or signs. Hence a gene or genes controlling stature is located in band Xp21 or regions immediately adjacent to this band. Since the absence of this region does not cause streak gonads, it does not contain genes controlling the formation of the ovaries. This appears to be the first example of a heritable chromosome deletion compatible with a normal phenotype and reproduction.

Entities:  

Mesh:

Year:  1979        PMID: 474618     DOI: 10.1002/ajmg.1320030110

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism.

Authors:  S P Kwan; L Kunkel; G Bruns; R J Wedgwood; S Latt; F S Rosen
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

2.  Localisation of Xp21 meiotic exchange points in Duchenne muscular dystrophy families.

Authors:  C J Bertelson; J A Bartley; A P Monaco; C Colletti-Feener; K Fischbeck; L M Kunkel
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

3.  Elucidation of structural abnormalities of the X chromosome using fluorescence in situ hybridisation with a Y chromosome painting probe.

Authors:  R T Howell; R Millener; S Thorne; J O'Loughlin; J Brassey; A McDermott
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

4.  Inactivation centers in the human X chromosome.

Authors:  Y Nakagome
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

5.  Isodicentric X chromosome in a moderately tall patient with gonadal dysgenesis: lack of effect of functional centromere on inactivation pattern.

Authors:  J Robertson; M J Faed; M A Lamont; A M Crowder
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

6.  Mapping DNA sequences in a human X-chromosome deletion which extends across the region of the Duchenne muscular dystrophy mutation.

Authors:  C Ingle; R Williamson; A de la Chapelle; R R Herva; K Haapala; G Bates; H F Willard; P Pearson; K E Davies
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

7.  Isolation of probes detecting restriction fragment length polymorphisms from X chromosome-specific libraries: potential use for diagnosis of Duchenne muscular dystrophy.

Authors:  M H Hofker; M C Wapenaar; N Goor; E Bakker; G J van Ommen; P L Pearson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  BrdU-Hoechst-Giemsa analysis of DNA replication in synchronized lymphocyte cultures. Study of human X and Y chromosomes.

Authors:  B Kałuzewski
Journal:  Chromosoma       Date:  1982       Impact factor: 4.316

9.  Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion.

Authors:  L M Kunkel; A P Monaco; W Middlesworth; H D Ochs; S A Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  The similarity of phenotypic effects caused by Xp and Xq deletions in the human female: a hypothesis.

Authors:  E Therman; B Susman
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.